105.50
0.00
(0.00%)
At close: January 17 at 2:40:22 PM CST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
297,579.00
190,066.00
149,913.00
201,562.00
Total Liabilities Net Minority Interest
130,763.00
91,737.00
67,296.00
75,450.00
Total Equity Gross Minority Interest
166,816.00
98,329.00
82,617.00
126,112.00
Total Capitalization
216,638.00
98,329.00
82,617.00
172,733.00
Common Stock Equity
166,816.00
98,329.00
82,617.00
126,112.00
Capital Lease Obligations
6,160.00
9,749.00
13,240.00
2,530.00
Net Tangible Assets
166,816.00
98,329.00
82,617.00
126,112.00
Working Capital
195,718.00
88,000.00
80,828.00
166,270.00
Invested Capital
216,638.00
125,040.00
114,881.00
176,900.00
Tangible Book Value
166,816.00
98,329.00
82,617.00
126,112.00
Total Debt
55,982.00
36,460.00
45,504.00
53,318.00
Net Debt
28,352.00
--
--
--
Share Issued
232,453.19
198,575.02
130,182.54
93,599.98
Ordinary Shares Number
232,453.19
198,575.02
130,182.54
93,599.98
12/31/2020 - 5/4/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FAB.L Fusion Antibodies plc
8.10
-7.43%
PYC.L Physiomics Plc
1.1250
+2.27%
AVTE Aerovate Therapeutics, Inc.
2.6200
+1.75%
SYRE Spyre Therapeutics, Inc.
22.27
+1.69%
CSCI COSCIENS Biopharma Inc.
2.7700
+2.21%
PASG Passage Bio, Inc.
0.5848
+1.46%
TENX Tenax Therapeutics, Inc.
6.00
-1.64%
GUTS Fractyl Health, Inc.
1.9400
-3.96%
CING Cingulate Inc.
4.5500
-4.01%
VOR Vor Biopharma Inc.
1.3900
+0.72%